Can medical cannabis help with cachexia?

Appetite is the effect cannabis is best known for, which makes cachexia the condition where expectation and evidence diverge most sharply. The distinction between losing your appetite and losing muscle is the whole of it.

The short answer

  • Cachexia is not the same as appetite loss. It is a wasting syndrome driven by the underlying illness, involving muscle loss.
  • The largest randomised trial was negative. A cannabis extract did not beat placebo on appetite or quality of life in cancer cachexia.
  • Eating more does not reverse it. That is what separates cachexia from starvation.
  • Nausea is a different question, and one with better evidence behind it.
  • Treating the underlying illness comes first, alongside specialist dietetic and palliative care input.

What cachexia actually is

A metabolic syndrome that comes with a serious underlying illness — most often advanced cancer, but also heart failure, COPD, kidney disease and HIV. It involves loss of skeletal muscle, with or without loss of fat, and it cannot be fully reversed by eating more.

That last point is what makes cachexia different from simple undernutrition, and it is why a medicine that increases appetite does not automatically help. The inflammatory and metabolic processes driving the muscle loss continue regardless of how much someone manages to eat.

It matters clinically because the two are often treated as the same problem. Poor appetite from nausea, taste changes or treatment side effects is a real and separate difficulty, and one where there is more to offer.

What the evidence shows

The definitive trial in this area was negative. A multicentre phase III study compared a cannabis extract, THC alone and placebo in patients with cancer-related anorexia-cachexia syndrome, and found no significant difference in appetite or quality of life.

The trial behind that paragraph

Strasser F, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. Journal of Clinical Oncology, 2006. The trial was stopped early for insufficient differences between study arms.

Read the paper →

That is an unusually clear result for this field, and it deserves to be stated plainly rather than buried. Later reviews have not overturned it. Where cannabinoids do have an established role in cancer care it is for chemotherapy-induced nausea and vomiting, which is a different indication with a different evidence base.

None of that means appetite never improves in individual patients. It means the controlled evidence does not support cachexia itself as a reason to prescribe.

What a specialist will look at instead

Whether the problem is genuinely cachexia, or a treatable symptom sitting on top of it. The second is far more actionable than the first.

Several of those overlap with questions covered in medical cannabis for nausea and appetite loss and cancer-related pain.

The general requirements — age, a documented diagnosis, the convention that two standard treatments have been tried, and access to your medical records — are covered in What are the requirements?

Risks worth weighing here in particular

People with cachexia are frequently frail, often elderly, and usually taking several other medicines. That combination raises the significance of side effects that would be minor in someone else.

Dizziness and sedation matter more when falls are already a risk. Drug interactions matter more when the medicines list is long. And the time and cost of pursuing a treatment with negative trial evidence is itself a cost, in a situation where time is often what there is least of.

That is not an argument for doing nothing. It is an argument for making sure the treatable symptoms have genuinely been addressed first.

If you want to take this further

The useful next step is a proper assessment, not a longer reading list. Gather your diagnosis, the treatments you have already tried and what happened with each, and a current list of your medicines — that is what a specialist needs in order to give you a straight answer.

The consultation itself, and what happens after it, is set out in What is the process to get a medical cannabis prescription? If cachexia is not the only thing you are being treated for, say so early: other conditions and other medicines change the assessment.

Frequently asked questions

Does medical cannabis help cachexia?

The controlled evidence does not support it. The largest randomised trial, in cancer-related anorexia-cachexia syndrome, found no significant difference between a cannabis extract, THC alone and placebo, and was stopped early.

Is cachexia the same as loss of appetite?

No. Cachexia is a wasting syndrome driven by an underlying illness and involves loss of skeletal muscle that eating more does not reverse. Appetite loss can accompany it, and can also occur on its own from nausea, pain or treatment side effects.

What about cannabis for chemotherapy sickness?

That is a different indication with a stronger evidence base, and one licensed cannabis-based medicine is recommended for chemotherapy-induced nausea and vomiting where standard anti-sickness medicines have not worked.

Can it be prescribed for weight loss in general?

Weight loss without a diagnosis is not an indication. A specialist would want to know what is causing it, and unexplained weight loss needs investigating rather than treating symptomatically.

Sources and further reading

Every factual statement on this page is drawn from the following public sources. Links open in a new tab and are not affiliated with Flora House.

  1. Strasser F, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome. Journal of Clinical Oncology (2006)
  2. NICE guideline NG144: Cannabis-based medicinal products
  3. NHS: Cancer
  4. NHS: Medical cannabis (and cannabis oils)
  5. MHRA: The supply, manufacture, importation and distribution of unlicensed cannabis-based products for medicinal use

Patient guide · Written by the Flora House editorial team · Last reviewed: 8 September 2026